Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Ocular Therapeutix Shares Climb More than 25% on Q4 Revenue and Phase 1 Wet AMD Clinical Data

Ocular Therapeutix shares set a new 52-week high price after the company reported preliminary FY/19 revenue results along with positive interim data from its Phase 1 clinical study of OTX-TKI for treatment of wet age-related macular degeneration. Ocular Ther...
Streetwise Reports | March 5, 2020 |

Kodiak Shares Soar on $225 Million Royalty Deal for Retinal Drug

Shares of Kodiak Sciences traded more than 100% higher at times after the company reported that it entered into a $225 million royalty agreement for the firm's KSI-301 used in the treatment of retinal vascular diseases including age-related macular degeneration and diabetic ey...
Streetwise Reports | December 3, 2019 |

IVERIC bio Shares Double After Announcing Phase 2b AMD Topline Data

Shares of IVERIC bio opened nearly 100% higher today after reporting that it successfully met its primary endpoint in its Phase 2b age-related macular degeneration study for Zimura. Early this morning, gene therapy focused biopharmaceutical company IVERIC bio Inc. (I...
Streetwise Reports | October 29, 2019 |

Have We Just Seen the First Short-Term Crack in the Stock Market Dam?

Stocks reached out for new 2020 highs yesterday, and have marginally overcome futures’ Monday session highs. Yet, they suffered a setback yesterday, and price action left the very short-term rising wedge. But the bulls erased a good deal of previous losses, and...
Monica Kingsley | February 19, 2020 |

EyeGate Pharma Shares Looking Up on Pivotal PRK Ocular Bandage Gel Study Data

EyeGate Pharmaceuticals shares opened nearly 85% higher today after the company reported select topline data demonstrating that it met its primary endpoint in its cornea wound repairs pivotal photorefractive keratectomy study using the firm's Ocular Bandage Gel eye drop. ...
Streetwise Reports | November 25, 2019 |

FDA Grants Ampio Pharma Approval to Begin Phase 1 Trial in COVID-19 Patients

Ampio Pharmaceuticals' shares traded higher after the company reported that the FDA cleared the firm to proceed with human trials of its Investigative New Drug application for intravenous AmpionTM for treatment in COVID-19 affected patients on supplemental oxygen. ...
Streetwise Reports | June 22, 2020 |

Market outlook: is the stock market selloff over?

Last week we explained why the market's short term outlook is bearish. The stock market is now making a pullback, and trade war news isn't helping bulls. Over the past year, tariff-related news has not been good for stocks in the short term. Technicals (short term, nex...
Troy Bombardia | August 7, 2019 |

The Many Opportunities the Fed Day Has Dealt Us

Volatile trading is calming down, revealing several opportunities. The euro has retraced its yesterday’s downswing, the Japanese yen is strengthening – just as the Canadian dollar is. Swiss franc is another currency we’re keeping a close eye on....
Nadia Simmons | September 19, 2019 |

This Is What the Crude-Oil-to-Gold Ratio Says About Oil Now

Many times in the past, the relationship between gold and oil gave us valuable clues about crude oil future moves. Will the history repeat itself once again? What can we infer about the next gold move from the chart below? Let’s examine the cu...
Nadia Simmons | October 29, 2019 |

Stock Bottom Reached? Don’t Bet the Farm Just Yet

As the markets grapple with the coronavirus story, the stock market is no exception. Jittery and volatile trading is what we’ve seen on Friday, January 24 already. In the heat of the moment, it’s easy to sell first and ask questions later. But t...
Monica Kingsley | February 4, 2020 |
1 2 3 4 5